Harmony Biosciences Holdings, Inc. 13F holders
Of the 44 funds followed here, 8 reported a position in Harmony Biosciences Holdings, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 3.6 million shares worth $130.1 million, 0.0% of its reported book.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 3,574,115 | $130.1 million | 0.0% | +416,476 | added | 30 June 2026 | 13F |
| Geode Capital Management | 1,442,649 | $52.5 million | 0.0% | +119,929 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 1,195,371 | $43.5 million | 0.1% | +118,000 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 959,136 | $34.9 million | 0.0% | +225,693 | added | 30 June 2026 | 13F |
| Millennium Management | 319,812 | $11.6 million | 0.0% | -634,547 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 319,810 | $11.6 million | 0.0% | -357,813 | trimmed | 30 June 2026 | 13F |
| Bridgewater Associates | 248,575 | $9.1 million | 0.0% | -2,931 | trimmed | 30 June 2026 | 13F |
| Norges Bank | 142,100 | $5.2 million | 0.0% | held | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 31 July 2026 | 13G | Vanguard Portfolio Management and 1 other | 2.9 million | 5.1% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 28 July 2026 | 13G/A | BlackRock, Inc. and 1 other | 6.5 million | 11.3% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 27 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 5 February 2026 | 13G/A | Fmr Llc and 3 others | 3.1 million | 5.4% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | Valor IV Pharma Holdings, LLC and 17 others | 1.8 million | 3.2% | 30 September 2025 | passive, other (13d-1(d)) | EDGAR |
| 5 November 2025 | 13G/A | Fmr Llc and 3 others | 3.8 million | 6.7% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 9 September 2026 | 47,140 | $42.07 | SEC |
| 3 September 2026 | 30,438 | $42.86 | SEC |
| 1 September 2026 | 166 | $39.38 | SEC |
| 24 August 2026 | 295 | $38.15 | SEC |
| 10 August 2026 | 16,419 | $38.41 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 47,140 on 9 September 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to HRMY by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.